Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery (AMIREMBOL)

Effect of Endovascular Inferior Mesenteric Artery Embolization on Colonic Perfusion Prior to Rectal Surgery for Rectal Tumor or Sigmoid Colon Surgery - A Single-center Feasibility Pilot Study.

The investigators hypothesize that a primary embolization, 3-4 weeks before surgery, would allow development of vascular collaterality, in particular for the marginal artery which will ensure a better colonic perfusion.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nimes, France, 30029
        • CHU Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old and less than 80 years old
  • Patient has rectal cancer or sigmoid colon cancer requiring surgical treatment

Exclusion Criteria:

  • The subject is participating in another study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient has a history of abdominal surgery
  • Patient suffers from a hemostasis disorder (hemophilia, von Willebrand disease, thrombocytopenia) and is on anticoagulant therapy.
  • Patient whose general condition appears too precarious or is taking corticosteroids or immunosuppressants leading to an unacceptable surgical risk.
  • Renal insufficiency with clearance <45ml / min
  • Known allergy to contrast media
  • Patient who had treatment of the abdominal aorta or its branches Reported pregnancy (the existence of effective contraception will be verified for women of childbearing age).
  • Anatomical variant at risk or absence of marginal artery highlighted at the time of arteriography.
  • Abnormality of the superior mesenteric artery
  • Historic occlusion of the inferior mesenteric artery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: embolization
proximal occlusion of the inferior mesenteric artery, before its divisional branches, by coils or plug 3-4 weeks prior to surgery.
Endovascular ligation of Inferior mesenteric artery
Other: No embolization
Endovascular ligation of Inferior mesenteric artery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
Digital oxymeter (%)
Prior to start of surgery
Arterial pressure after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
Average (mmHg)
Prior to start of surgery
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: Prior to start of surgery
Rectal resistance index measured by Doppler
Prior to start of surgery
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
Digital oxymeter (%)
60 seconds after surgery
Oxygen saturation of the colon after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
Digital oxymeter (%)
5 minutes after surgery
Arterial pressure in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
Average (mmHg)
60 seconds after surgery
Arterial pressure in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
Average (mmHg)
5 minutes after surgery
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 60 seconds after surgery
Rectal resistance index measured by Doppler
60 seconds after surgery
Colonic perfusion in the marginal artery after inferior mesenteric artery ligation between groups
Time Frame: 5 minutes after surgery
Rectal resistance index measured by Doppler
5 minutes after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of post-embolization complications
Time Frame: Day 5 post-emoblization
Yes/No
Day 5 post-emoblization
Presence of post-surgery complications
Time Frame: Hospital discharge (Day 7 after surgery)
Yes/No
Hospital discharge (Day 7 after surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Bertrand, MD, CHU Nîmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2020

Primary Completion (Actual)

June 24, 2021

Study Completion (Actual)

June 24, 2021

Study Registration Dates

First Submitted

August 9, 2018

First Submitted That Met QC Criteria

August 9, 2018

First Posted (Actual)

August 14, 2018

Study Record Updates

Last Update Posted (Actual)

August 4, 2021

Last Update Submitted That Met QC Criteria

August 3, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer, Rectum

Clinical Trials on embolization of the inferior mesenteric artery

3
Subscribe